Martina Brueckmann
0000-0003-1215-0746
Publication & Citation Trends
Most Cited Works
Publications
216 total
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease OA
Cited by 2
Semantic Scholar
Efficacy and Safety of Empagliflozin According to Background Diuretic Use in Heart Failure With Reduced Ejection Fraction: Post-Hoc Analysis of EMPEROR-Reduced. OA
Cited by 10
Semantic Scholar
Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction OA
Cited by 36
Semantic Scholar
Health status across major subgroups of patients with heart failure and preserved ejection fraction OA
Cited by 19
Semantic Scholar
Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled OA
Cited by 5
Semantic Scholar
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR‐Preserved trial OA
Cited by 23
Semantic Scholar
EFFECT OF PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY ON MORTALITY AND SUDDEN CARDIAC DEATH IN HEART FAILURE TREATED WITH SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS: AN ANALYSIS FROM THE EMPEROR-REDUCED TRIAL OA
Cited by 0
Semantic Scholar
Vascular Disease Burden, Outcomes, and Benefit with Empagliflozin in Heart Failure: Insights from the EMPEROR-Reduced Trial. OA
Cited by 5
Semantic Scholar
Research Topics
Diabetes Treatment and Management
(104)
Heart Failure Treatment and Management
(55)
Pancreatic function and diabetes
(54)
Atrial Fibrillation Management and Outcomes
(38)
Cardiovascular Function and Risk Factors
(31)
Frequent Co-Authors
Affiliations
Technische Hochschule Mannheim
Roche (United States)
St. Michael's Hospital
Boehringer Ingelheim (Germany)
Inserm